LITTLE KNOWN FACTS ABOUT HIV/AIDS MANAGEMENT.

Tenofovir disoproxil fumarate use raises hazard of nephrotoxicity and lowered bone mineral density; take into consideration choice (e.g., tenofovir alafenamide) in clients with or liable to renal disease or osteopenia/osteoporosis; use with caution in patients that are getting nephrotoxic agents almost all of the mutations possibly are inferior to